NCT04385810View on ClinicalTrials.gov

Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 27, 2020

Primary Completion Date

July 29, 2020

Study Completion Date

July 29, 2020

Conditions
Covid19Sars-CoV2
Interventions
PROCEDURE

Ophthalmologic exam

Direct exam and Slit lamp exam Shirmer test Retinophotography At inclusion, day 7, day 14 and discharge from hospital

Trial Locations (1)

75019

Fondation Adolphe de Rothschild, Paris

All Listed Sponsors
lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT04385810 - Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19 | Biotech Hunter | Biotech Hunter